Does ELRANATAMAB Cause Cytokine release syndrome? 131 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 131 reports of Cytokine release syndrome have been filed in association with ELRANATAMAB (Elrexfio). This represents 17.3% of all adverse event reports for ELRANATAMAB.
131
Reports of Cytokine release syndrome with ELRANATAMAB
17.3%
of all ELRANATAMAB reports
25
Deaths
76
Hospitalizations
How Dangerous Is Cytokine release syndrome From ELRANATAMAB?
Of the 131 reports, 25 (19.1%) resulted in death, 76 (58.0%) required hospitalization, and 11 (8.4%) were considered life-threatening.
Is Cytokine release syndrome Listed in the Official Label?
Yes, Cytokine release syndrome is listed as a known adverse reaction in the official FDA drug label for ELRANATAMAB.
What Other Side Effects Does ELRANATAMAB Cause?
Immune effector cell-associated neurotoxicity syndrome (44)
Death (42)
Pyrexia (42)
Pneumonia (40)
Cytomegalovirus infection (34)
Neutropenia (30)
Covid-19 (29)
Infection (28)
Cytomegalovirus infection reactivation (24)
Plasma cell myeloma (24)
What Other Drugs Cause Cytokine release syndrome?
AXICABTAGENE CILOLEUCEL (4,140)
CYCLOPHOSPHAMIDE (2,263)
TISAGENLECLEUCEL (1,660)
FLUDARABINE (1,458)
RITUXIMAB (1,404)
BLINATUMOMAB (952)
DEXAMETHASONE (853)
DOXORUBICIN (850)
BREXUCABTAGENE AUTOLEUCEL (827)
VINCRISTINE (771)
Which ELRANATAMAB Alternatives Have Lower Cytokine release syndrome Risk?
ELRANATAMAB vs ELRANATAMAB-BCMM
ELRANATAMAB vs ELTROMBOPAG
ELRANATAMAB vs ELTROMBOPAG OLAMINE
ELRANATAMAB vs ELUXADOLINE
ELRANATAMAB vs ELVITEGRAVIR